|
| [January 03, 2013] |
 |
Nocimed Scientific Abstract Has Been Accepted and Awarded as One of the "Best Papers" for the International Society for the Advancement of Spine Surgery (ISASS) 2013
REDWOOD CITY, Calif. --(Business Wire)--
Nocimed is pleased to announce that its scientific abstract entitled
"Non-invasive In-vivo MR Spectroscopy of Non-herniated versus Herniated
Painful Lumbar Discs" has been accepted and awarded as one of the�16
"Best Papers" from several hundred abstract submissions for oral podium
presentation at the International Society for the Advancement of Spine
Surgery (ISASS) 2013 annual conference being held April 3-5, 2013 in
Vancouver, Canada. This paper presents certain clinical MR spectroscopy
results from data that was non-invasively acquired in vivo from
non-herniated painful, herniated painful, and non-painful lumbar discs,
and subsequently post-processed and evaluated, via the company's
investigational Nociscan Virtual Discogram diagnostic platform. The
investigational Nociscan MRS exams were conducted immediately following
standard lumbar MRI via a commercial Siemens (News - Alert) 3T Verio MR scanner and
single voxel spectroscopy pulse sequence, using a custom acquisition
protocol developed by Nocimed and under a Nocimed-sponsored IRB-approved
clinical research study at The Orthopedic Center of St. Louis (TOCSL).
The podium presentation is scheduled to be delivered by Matt Gornet, MD,
a named co-author under the awarded paper and Principal Investigator for
the clinical Nociscan investigations at TOCSL.
About Nociscan™ Virtual Discogram™ and Sigpro™
The Nociscan Virtual Discogram is an investigational spine diagnostic
platform, nd is a new application of MR spectroscopy (MRS) to
non-invasively measure disc chemistry as a brief adjunct to standard MRI
exams. The Nociscan exam is performed by acquiring an MRS spectrum from
a disc nucleus using commercial MR scanners and MRS pulse sequences
already indicated for tissue chemistry assessment, but using a
proprietary procedural protocol being evaluated specifically for disc
spectroscopy. The raw acquired MRS data is then uploaded electronically,
via a secure web interface, to a proprietary "cloud"-based Sigpro MRS
signal post-processor. Sigpro automatically provides a final
post-processed spectrum for making quantitative measurements at spectral
peaks associated with certain chemicals. These chemical signatures for
the disc may then be assessed as potential chemical biomarkers for
correlation to disc pathologies such as degeneration and pain. The
investigational Nociscan Virtual Discogram was previously awarded "#1
Overall Best New Technology (News - Alert) in Spine Care for 2011" by Orthopedics
This Week at the North American Spine Society 2011 annual meeting in
November, 2011.
About Nocimed™, LLC
Nocimed, LLC's mission is to provide disruptive new medical diagnostic
platform technologies to address significant areas of unmet need in
substantial clinical and research markets. The Company's primary
emphasis is to deliver this via web or "cloud"-based
Software-as-a-Service (SaaS (News - Alert)) solutions, principally for diagnostic
imaging post-processing. The Company is initially developing these
solutions for musculoskeletal and pain indications - with initial focus
on discogenic low back pain, a leading reported cause of worker's
compensation and disability claims and patient-doctor visits for
middle-aged adults. Nocimed was founded in 2008 as a Delaware Limited
Liability Company, with its principal place of business in Redwood City,
CA (News - Alert), and is privately funded by qualified accredited investors. Further
information may be found at www.nocimed.com.
Any inquiries may be directed by phone to (650)241-1727, or by email to cwakeman@nocimed.com.
Nociscan Virtual Discogram, Sigpro, and other products and technologies
embody exclusive proprietary rights of Nocimed, LLC, including under
certain copyrights and granted patents and pending patent applications
in the United States and other territories. Nocimed™, Nociscan™, Virtual
Discogram™, Nocigram™, Sigpro™, and Autovox™ are proprietary trademarks
of Nocimed, LLC. All rights reserved.
CAUTION: Investigational device. Limited by Federal Law to
investigational use only.

[ InfoTech Spotlight's Homepage ]
|